Cargando…
Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes
• This is the first study to assess aPKCλ/ι expression in primary prostate cancer with metastatic disease. • A total of 43 patients with prostate cancer and its metastasis to the lymph node and/or bone were analyzed in this study. • We found no strong association between aPKCλ/ι expression and the p...
Autores principales: | Yokomizo, Yumiko, Kawahara, Takashi, Nagashima, Yoji, Ishiguro, Hitoshi, Kato, Ikuma, Yao, Masahiro, Miyamoto, Hiroshi, Uemura, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504077/ https://www.ncbi.nlm.nih.gov/pubmed/28697433 http://dx.doi.org/10.1016/j.ijscr.2017.06.047 |
Ejemplares similares
-
The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma
por: Ma, C Q, et al.
Publicado: (2014) -
Shared and independent functions of aPKCλ and Par3 in skin tumorigenesis
por: Vorhagen, Susanne, et al.
Publicado: (2018) -
The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity
por: Elbediwy, Ahmed, et al.
Publicado: (2019) -
aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1
por: Tian, Li, et al.
Publicado: (2019) -
An Essential Role of the Universal Polarity Protein, aPKCλ, on the Maintenance of Podocyte Slit Diaphragms
por: Hirose, Tomonori, et al.
Publicado: (2009)